GANX

Gain Therapeutics, Inc.

Pharmaceutical PreparationsNasdaq<br>Emerging growth company

Total Trades

7

Buys

5

Sells

1

Largest Trade

N/A

Insiders

4

Institutional Funds

38

Inst. Value

$1M+

Insider Trades

InsiderTitleTypeValueSharesPriceDate
RICHMAN ERIC IDirectorBUY$15K–$50K17K$1.22Jul 1, 2024
Riley Jeffrey ScottDirectorBUY$100K–$500K30K$3.86Apr 1, 2024
Alder MatthiasCEOEXERCISEN/A637Dec 22, 2023
Alder MatthiasCEOSELL<$1K206$2.46Dec 22, 2023
RICHMAN ERIC ICHIEF EXECUTIVE OF…BUY$1K–$15K2K$2.58May 27, 2022
RICHMAN ERIC ICHIEF EXECUTIVE OF…BUY$15K–$50K13K$2.79May 23, 2022
Calabrese SalvatoreCHIEF FINANCIAL OF…BUY$1M+3K$8100.00May 19, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 38 funds holding

FundShares
Potomac Capital Management, Inc.1.0M
Cambridge Investment Research Advisors, Inc.569K
DME Capital Management, LP492K
VANGUARD GROUP INC371K
GEODE CAPITAL MANAGEMENT, LLC314K
MARSHALL WACE, LLP252K
STATE STREET CORP158K
MORGAN STANLEY133K
LPL Financial LLC107K
Focus Partners Wealth78K
HRT FINANCIAL LP56K
GROUP ONE TRADING LLC54K
SIMPLEX TRADING, LLC48K
BENEDICT FINANCIAL ADVISORS INC38K
OMERS ADMINISTRATION Corp37K
GOLDMAN SACHS GROUP INC32K
Point72 Asset Management, L.P.32K
JANE STREET GROUP, LLC31K
Lighthouse Investment Partners, LLC23K
GSA CAPITAL PARTNERS LLP20K
View on Google Finance →